These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32696523)

  • 1. Safety of bioelectrical impedance analysis in advanced heart failure patients.
    Roehrich L; Suendermann S; Just IA; Knierim J; Mulzer J; Mueller M; Eulert-Grehn JJ; Hummel M; Starck C; Potapov E; Knosalla C; Falk V; Schoenrath F
    Pacing Clin Electrophysiol; 2020 Oct; 43(10):1078-1085. PubMed ID: 32696523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Results of Bioelectrical Impedance Analysis in Patients with Cardiac Implantable Electronic Devices.
    Garlini LM; Alves FD; Kochi A; Zuchinali P; Zimerman L; Pimentel M; Perry IS; Souza GC; Clausell N
    Braz J Cardiovasc Surg; 2020 Apr; 35(2):169-174. PubMed ID: 32369296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of feasibility and results of frailty assessment methods prior to left ventricular assist device implantation.
    Roehrich L; Sündermann SH; Just IA; Kopp Fernandes L; Stein J; Solowjowa N; Mulzer J; Mueller M; Hummel M; Knierim J; Potapov E; Falk V; Schoenrath F
    ESC Heart Fail; 2022 Apr; 9(2):1038-1049. PubMed ID: 34994094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of bioimpedance body composition analysis on function of implanted cardiac devices.
    Buch E; Bradfield J; Larson T; Horwich T
    Pacing Clin Electrophysiol; 2012 Jun; 35(6):681-4. PubMed ID: 22452409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of Bioelectrical Impedance Analysis in Patients Equipped With Implantable Cardioverter Defibrillators.
    Meyer P; Makhlouf AM; Mondouagne Engkolo LP; Trentaz F; Thibault R; Pichard C; Burri H
    JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):981-985. PubMed ID: 26903305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioimpedance analysis is safe in patients with implanted cardiac electronic devices.
    Chabin X; Taghli-Lamallem O; Mulliez A; Bordachar P; Jean F; Futier E; Massoullié G; Andonache M; Souteyrand G; Ploux S; Boirie Y; Richard R; Citron B; Lusson JR; Godet T; Pereira B; Motreff P; Clerfond G; Eschalier R
    Clin Nutr; 2019 Apr; 38(2):806-811. PubMed ID: 29525512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of QRS Duration and Ventricular Pacing on Clinical and Arrhythmic Outcomes in Continuous Flow Left Ventricular Assist Device Recipients: A Multicenter Study.
    Gopinathannair R; Roukoz H; Trivedi JR; Cowger J; Bhan A; Ravichandran A; Bhat G; Birks EJ; Slaughter MS; Ahmed MM
    J Card Fail; 2019 May; 25(5):355-363. PubMed ID: 30797964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac implantable electronic devices with a defibrillator component and all-cause mortality in left ventricular assist device carriers: results from the PCHF-VAD registry.
    Cikes M; Jakus N; Claggett B; Brugts JJ; Timmermans P; Pouleur AC; Rubis P; Van Craenenbroeck EM; Gaizauskas E; Grundmann S; Paolillo S; Barge-Caballero E; D'Amario D; Gkouziouta A; Planinc I; Veenis JF; Jacquet LM; Houard L; Holcman K; Gigase A; Rega F; Rucinskas K; Adamopoulos S; Agostoni P; Biocina B; Gasparovic H; Lund LH; Flammer AJ; Metra M; Milicic D; Ruschitzka F;
    Eur J Heart Fail; 2019 Sep; 21(9):1129-1141. PubMed ID: 31410955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of decreased peripheral congestion detected by Bioelectrical Impedance Vector Analysis (BIVA) in patients hospitalized for acute heart failure: BIVA prognostic value in acute heart failure.
    Santarelli S; Russo V; Lalle I; De Berardinis B; Vetrone F; Magrini L; Di Stasio E; Piccoli A; Codognotto M; Mion MM; Castello LM; Avanzi GC; Di Somma S;
    Eur Heart J Acute Cardiovasc Care; 2017 Jun; 6(4):339-347. PubMed ID: 27073131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arrhythmias in Patients with Cardiac Implantable Electrical Devices after Implantation of a Left Ventricular Assist Device.
    Rosenbaum AN; Kremers WK; Duval S; Sakaguchi S; John R; Eckman PM
    ASAIO J; 2016; 62(3):274-80. PubMed ID: 26809088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective Randomized Evaluation of Implantable Cardioverter-Defibrillator Programming in Patients With a Left Ventricular Assist Device.
    Richardson TD; Hale L; Arteaga C; Xu M; Keebler M; Schlendorf K; Danter M; Shah A; Lindenfeld J; Ellis CR
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29475875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous implantable cardioverter-defibrillator: First single-center experience with other cardiac implantable electronic devices.
    Kuschyk J; Stach K; Tülümen E; Rudic B; Liebe V; Schimpf R; Borggrefe M; Röger S
    Heart Rhythm; 2015 Nov; 12(11):2230-8. PubMed ID: 26073595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and acceptability of a self-measurement using a portable bioelectrical impedance analysis, by the patient with chronic heart failure, in acute decompensated heart failure.
    Huguel B; Vaugrenard T; Saby L; Benhamou L; Arméro S; Camilleri É; Langar A; Alitta Q; Grino M; Retornaz F
    Geriatr Psychol Neuropsychiatr Vieil; 2018 Jun; 16(2):145-154. PubMed ID: 29877181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Home monitoring after ambulatory implanted primary cardiac implantable electronic devices: The home ambulance pilot study.
    Parahuleva MS; Soydan N; Divchev D; Lüsebrink U; Schieffer B; Erdogan A
    Clin Cardiol; 2017 Nov; 40(11):1068-1075. PubMed ID: 28833266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Day by day telemetric care of patients treated with cardiac resynchronisation therapy: first Polish experience.
    Liberska A; Kowalski O; Mazurek M; Lenarczyk R; Jędrzejczyk-Patej E; Przybylska-Siedlecka K; Kozieł M; Morawski S; Podolecki T; Kowalczyk J; Pruszkowska P; Pluta S; Sokal A; Kalarus Z
    Kardiol Pol; 2016; 74(8):741-748. PubMed ID: 26898970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electromagnetic interference of endodontic equipments with cardiovascular implantable electronic device.
    Dadalti MT; da Cunha AJ; de Araújo MC; de Moraes LG; Risso Pde A
    J Dent; 2016 Mar; 46():68-72. PubMed ID: 26765669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of cardiac implantable electronic devices in the presence of left ventricular assist devices.
    Parikh V; Sauer A; Friedman PA; Sheldon SH
    Heart Rhythm; 2018 Jul; 15(7):1089-1096. PubMed ID: 29325978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous-flow ventricular assist device exchange is safe and effective in prolonging support time in patients with end-stage heart failure.
    Anand J; Singh SK; Hernández R; Parnis SM; Civitello AB; Cohn WE; Mallidi HR
    J Thorac Cardiovasc Surg; 2015 Jan; 149(1):267-75, 278.e1. PubMed ID: 25312232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter-defibrillators and survival in advanced heart failure patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysis.
    Elkaryoni A; Badarin FA; Khan MS; Ellakany K; Potturi N; Poonia J; Kennedy KF; Magalski A; Sperry BW; Wimmer AP
    Europace; 2019 Sep; 21(9):1353-1359. PubMed ID: 31086951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.